TextBiz: OHR Pharmaceutical Inc (2017)
Ohr Pharmaceutical and Cold Spring Harbor Laboratory Announce Joint Venture to Develop Trodusquemine and Related Analogs | Business Wire
Ohr Pharmaceutical - 2/6/2015 | Cowen
Posterior Segment Company Showcase - Ohr pharmaceutical
Ohr Pharmaceutical Provides Update on Squalamine Study
CEO Invests in Ohr Pharmaceutical
Ohr Pharmaceutical (OHRP) Presents At 2017 Marcum Microcap Conference - Slideshow (NASDAQ:NBSE) | Seeking Alpha
Ohr Pharmaceutical (OHRP) Presents At 2017 Marcum Microcap Conference - Slideshow (NASDAQ:NBSE) | Seeking Alpha
Ohr Pharmaceuticals is determined to show efficacy for Squalamine despite setbacks - Pharmaceutical Technology
Ohr Pharmaceutical (OHRP) Presents At 2017 Marcum Microcap Conference - Slideshow (NASDAQ:NBSE) | Seeking Alpha
Pittsburgh's newest public company could debut next week as Ohr Pharmaceutical shareholders approve merger with NeuBase Therapeutics - Pittsburgh Business Times
Ohr Pharmaceutical presents data from OHR-102 study
CEO Invests in Ohr Pharmaceutical
LifeX's NeuBase Therapeutics is acquired by Ohr Pharmaceutical | Pittsburgh Post-Gazette
OHR Pharmaceutical - Crunchbase Company Profile & Funding
Ohr Pharmaceutical (OHRP) Presents At 2017 Marcum Microcap Conference - Slideshow (NASDAQ:NBSE) | Seeking Alpha
Posterior Segment Company Showcase - Ohr pharmaceutical
Posterior Segment Company Showcase - Ohr pharmaceutical
Ohr Pharmaceutical Provides Update on Squalamine Study
Posterior Segment Company Showcase - Ohr pharmaceutical
TextBiz: OHR Pharmaceutical Inc (2013)
EX-99.1 2 ex-99_1.htm SLIDE ADDRESS FOR PRESENTATION OHR
Ohr Pharmaceutical (@OhrPharma) / Twitter
citybizlist : Philadelphia : Ohr Pharmaceutical Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics
Ohr Pharmaceutical says it has funds to complete Ph III eye drug trial
Posterior Segment Company Showcase - Ohr pharmaceutical
